No proof FDA OK'd phantom recall

September 23, 2010
Johnson & Johnson failed to produce any past agreement between the company and the Food and Drug Administration that would prove without doubt that regulators allowed a clandestine recall of defective Motrin products on Wednesday.
Read more at:http://rss.cnn.com/~r/rss/money_topstories/~3/1gKLIx38oS8/index.htm

Site Created by finaceandbankingnewsnow.com